Sinocare Inc (300298) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.072x

Based on the latest financial reports, Sinocare Inc (300298) has a cash flow conversion efficiency ratio of 0.072x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥264.19 Million ≈ $38.66 Million USD) by net assets (CN¥3.67 Billion ≈ $537.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Sinocare Inc worth for the company's overall valuation and market capitalisation.

Sinocare Inc - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Sinocare Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sinocare Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sinocare Inc ranked by their cash flow conversion efficiency. Explore how high is Sinocare Inc's earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Cyient Limited
NSE:CYIENT
0.071x
Changjiang Publishing & Media Co Ltd
SHG:600757
0.035x
Fras-le S.A
SA:FRAS3
0.130x
Kidswant Children Products Co.Ltd.
SHE:301078
N/A
Zillow Group Inc
NASDAQ:ZG
0.045x
TianJin 712 Communication & Broadcasting Co Ltd
SHG:603712
-0.055x
TTW Public Company Limited
BK:TTW
0.045x
Zbit Semiconductor Inc. A
SHG:688416
N/A

Annual Cash Flow Conversion Efficiency for Sinocare Inc (2008–2024)

The table below shows the annual cash flow conversion efficiency of Sinocare Inc from 2008 to 2024. View 300298 stock price and chart for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥3.77 Billion
≈ $551.61 Million
CN¥631.29 Million
≈ $92.38 Million
0.167x -20.94%
2023-12-31 CN¥3.47 Billion
≈ $507.88 Million
CN¥735.15 Million
≈ $107.57 Million
0.212x +40.36%
2022-12-31 CN¥3.14 Billion
≈ $460.00 Million
CN¥474.39 Million
≈ $69.42 Million
0.151x -12.21%
2021-12-31 CN¥2.79 Billion
≈ $408.61 Million
CN¥480.03 Million
≈ $70.24 Million
0.172x -6.63%
2020-12-31 CN¥2.74 Billion
≈ $401.11 Million
CN¥504.64 Million
≈ $73.84 Million
0.184x -6.72%
2019-12-31 CN¥2.65 Billion
≈ $387.62 Million
CN¥522.81 Million
≈ $76.50 Million
0.197x +62.15%
2018-12-31 CN¥2.62 Billion
≈ $383.83 Million
CN¥319.27 Million
≈ $46.72 Million
0.122x -30.65%
2017-12-31 CN¥1.39 Billion
≈ $203.34 Million
CN¥243.89 Million
≈ $35.69 Million
0.176x +10.25%
2016-12-31 CN¥1.28 Billion
≈ $186.99 Million
CN¥203.42 Million
≈ $29.77 Million
0.159x +62.46%
2015-12-31 CN¥1.24 Billion
≈ $181.47 Million
CN¥121.52 Million
≈ $17.78 Million
0.098x -28.90%
2014-12-31 CN¥1.11 Billion
≈ $162.61 Million
CN¥153.15 Million
≈ $22.41 Million
0.138x +13.95%
2013-12-31 CN¥946.01 Million
≈ $138.43 Million
CN¥114.42 Million
≈ $16.74 Million
0.121x -20.83%
2012-12-31 CN¥845.18 Million
≈ $123.68 Million
CN¥129.12 Million
≈ $18.89 Million
0.153x -68.09%
2011-12-31 CN¥179.51 Million
≈ $26.27 Million
CN¥85.93 Million
≈ $12.57 Million
0.479x -34.81%
2010-12-31 CN¥91.35 Million
≈ $13.37 Million
CN¥67.08 Million
≈ $9.82 Million
0.734x -29.18%
2009-12-31 CN¥41.49 Million
≈ $6.07 Million
CN¥43.03 Million
≈ $6.30 Million
1.037x +136.80%
2008-12-31 CN¥17.42 Million
≈ $2.55 Million
CN¥7.63 Million
≈ $1.12 Million
0.438x --

About Sinocare Inc

SHE:300298 China Medical Devices
Market Cap
$1.28 Billion
CN¥8.76 Billion CNY
Market Cap Rank
#7876 Global
#1788 in China
Share Price
CN¥15.63
Change (1 day)
+0.26%
52-Week Range
CN¥13.65 - CN¥20.29
All Time High
CN¥47.34
About

Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People's Republic of China. It offers blood glucose and pressure monitors; point of care testing products; digital management tool solutions; non-invasive screening products; and PTS and Trividia products. The company provides its products for the patients with chronic disease… Read more